The latest update is out from Coya Therapeutics, Inc. (COYA).
Coya Therapeutics, Inc. successfully held its Annual Meeting, where stockholders voted in favor of expanding the company’s Equity Incentive Plan, allowing for an additional 750,000 shares to be issued, totaling 2,571,070 shares. Additionally, two Class II directors were elected for a three-year term, and the appointment of Weaver and Tidwell, L.L.P. as the company’s independent auditors for the upcoming fiscal year was ratified. These decisions reflect stockholder confidence and pave the way for Coya Therapeutics’ growth and governance stability.
For an in-depth examination of COYA stock, go to TipRanks’ Stock Analysis page.
